Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials

INTRODUCTION: Metformin is the first choice drug in the treatment of type 2 diabetes mellitus but its administration may be linked to gastrointestinal adverse events limiting its use. OBJECTIVES: The objective of this systematic review and meta-analysis was to assess the risk of gastrointestinal adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabrdalik, Katarzyna, Skonieczna-Żydecka, Karolina, Irlik, Krzysztof, Hendel, Mirela, Kwiendacz, Hanna, Łoniewski, Igor, Januszkiewicz, Kornelia, Gumprecht, Janusz, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524196/
https://www.ncbi.nlm.nih.gov/pubmed/36187122
http://dx.doi.org/10.3389/fendo.2022.975912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524196/
https://www.ncbi.nlm.nih.gov/pubmed/36187122
http://dx.doi.org/10.3389/fendo.2022.975912

Ejemplares similares